| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harrow, Inc. (HROW) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 8 sells. HROW is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.99M | $126.64M | - | |
| CFO | 837.8K | $35.53M | - | |
| 10% | 70.0K | $2.97M | - | |
| Other | 30.0K | $1.27M | - | |
| Other | 15.0K | $636.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2020 | Opaleye Management Inc.60 | 10% Owner | Buy | 50,000 | $5.73 | $286,508.30 | +0.7% | |
| May 22, 2020 | Opaleye Management Inc.60 | 10% Owner | Buy | 25,900 | $4.85 | $125,665.89 | +0.3% | |
| Nov 11, 2019 | Kammer Robert J | Director | Sell | 6,500 | $4.75 | $30,875.00 | -0.8% | |
| Oct 7, 2019 | Kammer Robert J | Director | Sell | 6,500 | $5.25 | $34,125.00 | -0.8% | |
| Sep 9, 2019 | Kammer Robert J | - | Sell | 6,500 | $5.67 | $36,855.00 | -0.8% | |
| Aug 12, 2019 | Kammer Robert J | - | Sell | 6,500 | $6.89 | $44,785.00 | -0.8% | |
| Jul 15, 2019 | Kammer Robert J | Director | Sell | 6,500 | $7.91 | $51,415.00 | -0.8% | |
| Jun 3, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.78 | $57,800.00 | -1.2% | |
| May 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $4.57 | $45,700.00 | -1.2% | |
| Apr 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $4.77 | $47,700.00 | -1.2% |